Although the effects of RhoA activation in the progression of various cancers are still contradictory1,24–26,31, both the in vitro and in vivo results of our study demonstrated that 3MC-induced RhoA inhibition contributed to RCC-tumor-promoting effects. The gene discussed is RHOA; the disease is neoplasm.